Genmab A/S (GMAB)
28.20
+0.21
(+0.75%)
USD |
NASDAQ |
May 31, 16:00
28.19
-0.01
(-0.04%)
After-Hours: 20:00
Genmab 1 Year Total Returns (Daily): -28.08% for May 31, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 31, 2024 | -28.08% |
| May 30, 2024 | -28.74% |
| May 29, 2024 | -31.09% |
| May 28, 2024 | -31.04% |
| May 24, 2024 | -31.17% |
| May 23, 2024 | -29.81% |
| May 22, 2024 | -29.64% |
| May 21, 2024 | -30.00% |
| May 20, 2024 | -28.70% |
| May 17, 2024 | -27.58% |
| May 16, 2024 | -28.64% |
| May 15, 2024 | -28.29% |
| May 14, 2024 | -29.17% |
| May 13, 2024 | -30.06% |
| May 10, 2024 | -28.53% |
| May 09, 2024 | -27.21% |
| May 08, 2024 | -28.66% |
| May 07, 2024 | -27.45% |
| May 06, 2024 | -28.09% |
| May 03, 2024 | -27.42% |
| May 02, 2024 | -32.21% |
| May 01, 2024 | -29.64% |
| April 30, 2024 | -32.48% |
| April 29, 2024 | -30.33% |
| April 26, 2024 | -31.07% |
| Date | Value |
|---|---|
| April 25, 2024 | -33.20% |
| April 24, 2024 | -31.48% |
| April 23, 2024 | -30.32% |
| April 22, 2024 | -29.32% |
| April 19, 2024 | -29.24% |
| April 18, 2024 | -32.01% |
| April 17, 2024 | -33.56% |
| April 16, 2024 | -29.22% |
| April 15, 2024 | -29.03% |
| April 12, 2024 | -25.20% |
| April 11, 2024 | -23.74% |
| April 10, 2024 | -22.89% |
| April 09, 2024 | -22.92% |
| April 08, 2024 | -23.20% |
| April 05, 2024 | -22.26% |
| April 04, 2024 | -20.98% |
| April 03, 2024 | -21.99% |
| April 02, 2024 | -20.66% |
| April 01, 2024 | -19.84% |
| March 28, 2024 | -19.42% |
| March 27, 2024 | -18.88% |
| March 26, 2024 | -17.48% |
| March 25, 2024 | -19.75% |
| March 22, 2024 | -17.48% |
| March 21, 2024 | -19.61% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-39.80%
Minimum
Jun 16 2022
101.5%
Maximum
Jul 22 2020
20.30%
Average
16.98%
Median
Apr 27 2023
1 Year Total Returns (Daily) Benchmarks
| Ascendis Pharma A/S | 55.38% |
| Novo Nordisk A/S | 70.65% |
| Galecto Inc | -72.24% |
| Evaxion Biotech AS | -75.86% |
| IO Biotech Inc | -43.03% |